STAT NEWS

The World Health Organization said Wednesday that it would launch a multiarm, multicountry clinical trial for potential coronavirus therapies, part of an aggressive effort to jumpstart the global search for drugs to treat Covid-19.

360 Dx

NEW YORK – Bioneer said Thursday it has received CE marking for its AccuPower COVID-19 Real-Time RT-PCR Kit and AccuPower SARS-CoV-2 Real-Time RT-PCR Kit and has signed a $1.9 million agreement to supply its ExiStation molecular diagnostics system and coronavirus detection kits in Romania.

360 Dx

NEW YORK – SolGent said on Thursday that it has received the CE mark for its DiaPlexQ Novel Coronavirus (2019-nCoV) Detection assay, as well as authorization from regulatory authorities in Korea and the Philippines.

HealthImaging

Imaging experts continue to gain a better understanding of the lung abnormalities seen in the computed tomography scans of patients with the coronavirus. And a new letter to the editor builds upon that research, tracing the evolution of such findings from symptom onset to hospital discharge.

FiercePharma

Among a long list of biopharma companies developing vaccines against the novel coronavirus, China’s CanSino Biologics and Massachusetts-based Moderna Therapeutics are so far the front-runners.

AAA SCIENCE

How many COVID-19 cases have gone undetected? And are those who had mild cases of the disease—perhaps so mild they dismissed it as a cold or allergies—immune to new infections? If so, they could slow the spread of the burgeoning pandemic.

MPR The Right Dose of Information

The Food and Drug Administration (FDA) has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).

Reuters

(Reuters) – The U.S. Food and Drug Administration has approved the first rapid coronavirus diagnostic test, with a detection time of about 45 minutes, as the United States struggles to meet the demand for coronavirus testing.

FiercePharma

Despite high hopes for its game-changing monthly HIV regimen Cabenuva, GlaxoSmithKline’s ViiV Healthcare went back to the drawing board after the FDA slammed the drug’s manufacturing late last year. But Canadian regulators had few concerns and now Cabenuva will be ready for launch in its first global market.

Regulatory Focus

In light of the need to act quickly and efficiently to respond to the COVID-19 public health emergency, the US Food and Drug Administration (FDA) on Friday said that it anticipates that prior public participation will not be feasible or appropriate before FDA implements COVID-19-related guidance documents.

FiercePharma

Reuters

GENEVA (Reuters) – Coronavirus can sicken or kill young people as well and they must also avoid mingling and spreading it to older and more vulnerable people, the World Health Organization said on Friday.